Effect of Combination Treatment for Hypothyroidism on Renal Function in Patients with Hypothyroidism

Abstract

Objective. To improve known methods of diagnosing kidney damage in patients suffering from hypothyroidism with elements of metabolic syndrome, to study the effect of combined treatment on renal function. Materials and methods. The study included 240 patients with primary hypothyroidism (among them — 130 patients with primary hypothyroidism with components of the metabolic syndrome). All patients were divided into 2 groups: the I group included 42 patients with hypothyroidism without obesity (age 44.8 ± 5.7 years; body mass index (BMI) 21.3 ± 2.6 kg/m2); group II — 45 patients with hypothyroidism and abdominal obesity (age 43.8 ± 6.1 years; BMI 33.4 ± 4.8 kg/m2). The control group included 20 healthy individuals (age 43.5 ± 5.9 years; BMI 22.0 ± 2.4 kg/m2). Kidney damage was detected in violation of glomerular filter permeability — occurrence of albuminuria and parameters of glomerular filtration rate (GFR) were determined using CKD-EPI formulas. The concentration of monocyte chemoattractant protein-1 (MCP-1), leptin, insulin was determined by immunoenzyme assay. Results. During the correlation analysis, between GFR in patients of group I we have established: moderate inverse correlation between the level of GFR and thyroid stimulating hormone (TSH) (r = 0.571), GFR and vascular endothelial growth factor (r = –0.616), GFR anf interleukin-6 (IL-6) (r = –0.418), total cholesterol (ChS) (r = –0.311), GFR and insulin resistance index (IIR) (r = –0.606) and weak inverse relationship between level of GFR and MCP-1 (r = –0.2917). In the II group of patients, a strong direct correlation between the level of GFR and IIR (r = 0.819), Caro index (r = 0.793) and a strong inverse correlation between GFR and TSH (r = –0.782), GFR and HOMA index (r = –0.875), moderate inverse correlation between the levels of GFR and ChS (r = –0.577), leptin (r = –0.476), GFR and IL-6 (r = –0.418), GFR and glucose (r = –0.436) and vascular endothelial growth factor (r = –0.337). Conclusions. In patients with uncompensated hypothyroidism, we have detected renal dysfunction, which was characterized by a decrease in GFR, albuminuria appearance. During combined treatment with the inclusion of angiotensin-converting enzyme inhibitor (enalapril) and atorvastatin, we have noted pathogenetically grounded effect on markers of functional kidney injury.

Authors and Affiliations

O. N. Didushko, V. I. Pankivn

Keywords

Related Articles

Glycemic screening and recurrent carbohydrate metabolism disorders with endocrine pathology

The use of glycated hemoglobin for diabetes mellitus (DM) diagnosis is recommended by World Health Organization as of 2011. The level of glycated hemoglobin (HbA1c) ≥ 6.5 % is a diagnostic criterion for DM but HbA1c leve...

Evaluating the quality of life in children and adolescents with type 1 diabetes mellitus on pump insulin therapy, considering the carbohydrate value in Uzbek national foods

Background. Type 1 diabetes mellitus (DM) in children and adolescents is a complex problem throughout the world. The onset of the disease at an early age and development of acute and chronic complications already at youn...

Opportunities of Neurometabolic Therapy in the Treatment of Neurological Complications of Diabetes Mellitus

The review describes the effect of neurometabolic therapy with Actovegin on glucose uptake, as well as antioxidant, antihypoxant and other mechanisms of action of the drug. The possibilities of neurometabolic therapy in...

Adrenal Hyperandrogenism: Multidisciplinary Approach to Solving Problemss

Prevalence and possible consequences of the hyperandrogenic states in women of reproductive age stipulate the importance of timely differential diagnosis of hyperandrogenism. Taking into account the level of the developm...

Download PDF file
  • EP ID EP207106
  • DOI -
  • Views 57
  • Downloads 0

How To Cite

O. N. Didushko, V. I. Pankivn (2016). Effect of Combination Treatment for Hypothyroidism on Renal Function in Patients with Hypothyroidism. Міжнародний ендокринологічний журнал, 1(73), 97-103. https://europub.co.uk/articles/-A-207106